Thr423

Thr423 is a protein encoded by the THR423 gene located on chromosome 12q21.3. The gene spans approximately 7.8 kilobases and consists of nine exons that collectively produce a single transcript. The encoded protein comprises 462 amino acids, with a predicted molecular weight of 50.3 kDa and an isoelectric point around 6.1. Structural prediction analyses indicate the presence of a central α‑helical domain flanked by a cysteine-rich N‑terminal motif and an acidic C‑terminal tail. The only post‑translational modification identified to date is phosphorylation of threonine 423, located in the C‑terminal region; this modification is mediated by protein kinase Cδ and is reported to enhance Thr423’s interaction with the co‑activator PGC‑1α.

Functional studies in cultured hepatocytes and murine liver models suggest that Thr423 plays a role in regulating hepatic lipid metabolism. Overexpression of Thr423 leads to increased fatty acid β‑oxidation and decreased triglyceride synthesis, while knockdown results in lipid accumulation and altered expression of key enzymes such as CPT1A and ACC. The protein is also implicated in insulin signaling, where Thr423 phosphorylation appears to modulate insulin receptor substrate‑1 stability, thereby influencing glucose uptake.

Clinically, the THR423 locus has been linked to metabolic syndrome in genome‑wide association studies. Single‑nucleotide polymorphisms in the promoter region, particularly the −138 G>C variant, are associated with decreased gene expression and increased body mass index in European populations. No pathogenic mutations have been definitively tied to monogenic diseases, and current evidence does not implicate Thr423 in cancer or neurodegeneration.

Research efforts are oriented toward elucidating the full spectrum of Thr423’s interacting partners. Recent proteomic screens have identified associations with the mTOR pathway, the oxidative phosphorylation complex, and the small GTPase ARF6. Future studies aim to determine whether modulation of Thr423 activity could serve as a therapeutic target for metabolic disorders.